Indrayani Biotech Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Indrayani Biotech zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Hospitality earnings growth | 33.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Indrayani Biotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 1,711 | 45 | N/A | N/A | N/A |
9/30/2023 | 1,780 | 69 | 116 | 370 | N/A |
6/30/2023 | 1,796 | 97 | N/A | N/A | N/A |
3/31/2023 | 1,629 | 87 | -77 | 162 | N/A |
12/31/2022 | 1,309 | 121 | N/A | N/A | N/A |
9/30/2022 | 1,001 | 98 | -102 | -82 | N/A |
6/30/2022 | 729 | 56 | N/A | N/A | N/A |
3/31/2022 | 616 | 44 | 29 | 41 | N/A |
12/31/2021 | 515 | -4 | N/A | N/A | N/A |
9/30/2021 | 421 | -33 | N/A | N/A | N/A |
6/30/2021 | 320 | -52 | N/A | N/A | N/A |
3/31/2021 | 212 | -112 | -4 | 3 | N/A |
6/30/2020 | 533 | -45 | N/A | N/A | N/A |
3/31/2020 | 499 | 8 | N/A | N/A | N/A |
6/30/2019 | N/A | -1 | N/A | N/A | N/A |
3/31/2019 | N/A | -1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von 526445 über der Sparquote liegt (6.7%).
Ertrag vs. Markt: Insufficient data to determine if 526445's earnings are forecast to grow faster than the Indian market
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von 526445 in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Insufficient data to determine if 526445's revenue is forecast to grow faster than the Indian market.
Hohe Wachstumseinnahmen: Insufficient data to determine if 526445's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von 526445 in 3 Jahren voraussichtlich hoch sein wird